H
Hui Nam Pak
Researcher at Yonsei University
Publications - 405
Citations - 11302
Hui Nam Pak is an academic researcher from Yonsei University. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 42, co-authored 405 publications receiving 9169 citations. Previous affiliations of Hui Nam Pak include Cedars-Sinai Medical Center & Korea University.
Papers
More filters
Journal ArticleDOI
The Effect of Integrated Care Management on Dementia in Atrial Fibrillation.
Pil Sung Yang,Jung Hoon Sung,Eunsun Jang,Hee Tae Yu,Tae Hoon Kim,Jae Sun Uhm,Jong Youn Kim,Hui Nam Pak,Moon Hyoung Lee,Gregory Y.H. Lip,Boyoung Joung +10 more
TL;DR: The stratified analysis showed that the ABC pathway reduced the risk of dementia regardless of sex, comorbidities, and in patients with high stroke risk.
Journal ArticleDOI
Torsade de pointes induced by short-term oral amiodarone therapy.
TL;DR: Two cases of amiodarone-induced torsade de pointes (TdP) are reported shortly after administration of a low dose of oral amioarone, in the absence of predisposing factors.
Journal ArticleDOI
Catheter Ablation Improves Mortality and Other Outcomes in Real-World Patients With Atrial Fibrillation
Pil Sung Yang,Jung Hoon Sung,Eunsun Jang,Hee Tae Yu,Tae Hoon Kim,Jae Sun Uhm,Jong Youn Kim,Hui Nam Pak,Moon Hyoung Lee,Boyoung Joung +9 more
TL;DR: Blation may be associated with lower risk of death, heart failure admission, and ischemic stroke/systemic embolism in real‐world Asian patients with AF.
Journal ArticleDOI
Relation of Chronic Obstructive Pulmonary Disease to Cardiovascular Disease in the General Population.
Shinjeong Song,Pil Sung Yang,Tae Hoon Kim,Jae Sun Uhm,Hui Nam Pak,Moon Hyoung Lee,Boyoung Joung +6 more
TL;DR: COPD was associated with all-cause mortality, but not with cardiovascular mortality and SCD, whereas poor pulmonary function wasassociated with a heightened cardiovascular risk.
Journal ArticleDOI
Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
Oh Hyun Lee,Jung Sun Kim,Hui Nam Pak,Geu Ru Hong,Chi Young Shim,Jae Sun Uhm,In Jeong Cho,Boyoung Joung,Cheol Woong Yu,Hyun Jong Lee,Woong Chol Kang,Eun-Seok Shin,Rak Kyeong Choi,Do Sun Lim,Yangsoo Jang +14 more
TL;DR: Percutaneous LAA occlusion in nonvalvular atrial fibrillation patients with LAA thrombus may be a safe and feasible alternative to anticoagulation in select patients at a high risk of bleeding or contraindication to antICOagulation, or in whom anticoAGulation failed to prevent stroke.